Global vaccines market to be worth $20.8 billion in 2015, says Visiongain

The worldwide vaccines market will reach a value of $20.8 billion in 2015, nearly double the $10.7 billion sales generated in 2010, according to Vaccine Manufacturing Technology and Services: World Market 2011-2021, a new report form business information provide Visiongain.

Markets and R&D pipelines for vaccines remain strong, with opportunities for vaccine manufacturing specialists. Pharmaceutical companies and contract manufacturing organizations (CMOs) will benefit. In 2011, leading manufacturers of vaccines include Sanofi, Merck & Co and GlaxoSmithKline. This new study forecasts potential revenues for vaccines at total world and submarket levels to 2021. It also shows revenue predictions for contract vaccine manufacturing. There are forecasts of vaccine volumes (by dose), including geographical production data.

Sharmarke Mohamed, health care industry analyst at Visiongain, says: "Vaccines are responsible for some of the greatest public health triumphs. Those achievements include the eradication of naturally-occurring smallpox. Historically, the vaccines market had a wide range of companies vying for market share. However, small-molecule therapies took center stage at the expense of vaccines.”